GlaxoSmithKline S.A.E (EGX:BIOC)

Market Cap	4.05B
Revenue (ttm)	3.52B
Net Income (ttm)	146.49M
Shares Out	83.51M
EPS (ttm)	1.75
PE Ratio	27.64
Forward PE	n/a
Dividend	0.75 (1.55%)
Ex-Dividend Date	Jul 18, 2024

Volume	412,229
Average Volume	249,424
Open	46.31
Previous Close	46.31
Day's Range	46.25 - 49.65
52-Week Range	27.01 - 50.79
Beta	0.87
RSI	66.25
Earnings Date	Aug 14, 2025

About GlaxoSmithKline S.A.E

GlaxoSmithKline S.A.E. engages in production of pharmaceutical chemicals. The company is involved in manufacture of general and specialty medicines, and vaccines. GlaxoSmithKline S.A.E. was founded in 1981 and is based in London, the United Kingdom. GlaxoSmithKline S.A.E operates as a subsidiary of Glaxo Group Limited.

• Industry: Pharmaceutical Preparations
• Founded: 1981
• Employees: 800
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: BIOC

Financial Performance

In 2024, GlaxoSmithKline S.A.E's revenue was 2.99 billion, an increase of 33.51% compared to the previous year's 2.24 billion. Earnings were 173.98 million, an increase of 187.78%.